Published: 7 August 2020
Author(s): Sophie Frantz, Bernhard Schulte-Hubbert, Michael Halank, Dirk Koschel, Martin Kolditz
Section: Original article

Pneumonia remains an important health concern in the western world, with highly variable mortality rates [1]. Initial risk stratification to objectify prognosis is the first step in managing patients with pneumonia, and scores like the CRB-65 or qSOFA have repeatedly been validated for initial screening of immunocompetent at risk- patients with pneumonia and sepsis [2–5]. Immunosuppression (IS) is a relevant risk factor for developing pneumonia [6] and for poor prognosis in pneumonia [7]. A recent worldwide study showed a high 18% prevalence of IS in patients with pneumonia presenting from the community [8].


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.